Literature DB >> 1336592

Beta-endorphin processing and cellular origins in rat spinal cord.

Howard B Gutstein1, David M Bronstein, Huda Akil.   

Abstract

While enkephalin and dynorphin peptides have been well characterized in the spinal cord, the cellular localization of beta-endorphin (beta E) and the processing of pro-opiomelanocortin (POMC) to beta E and other non-opioid peptides in the cord have not been extensively investigated. Other investigators have characterized the various beta E forms present in rat spinal cord regions. Previous studies have also suggested that spinal POMC content is entirely derived from supraspinal sources. However, high proportions of beta E precursors present in spinal cord sieving profiles led us to suspect the presence of POMC cell bodies intrinsic to the cord. In this study, we performed thoracic spinal cord lesions on a group of animals and demonstrated the persistence of about one-third of control levels of beta E immunoreactivity (beta E-IR) below the level of the lesions. We also characterized POMC processing in various regions of the spinal cord both before and after lesioning. These data suggested that there may be intrinsic POMC/endorphinergic neuronal systems in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336592     DOI: 10.1016/0304-3959(92)90265-D

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  2 in total

1.  Authentic cell-specific and developmentally regulated expression of pro-opiomelanocortin genomic fragments in hypothalamic and hindbrain neurons of transgenic mice.

Authors:  J I Young; V Otero; M G Cerdán; T L Falzone; E C Chan; M J Low; M Rubinstein
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

2.  Enkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization study.

Authors:  Juan Carlos G Marvizón; Wenling Chen; Niall Murphy
Journal:  J Comp Neurol       Date:  2009-11-01       Impact factor: 3.215

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.